openPR Logo
Press release

Investigation announced for Investors in Cronos Group Inc. (NASDAQ: CRON) over potential Securities Laws Violations

03-09-2020 10:39 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Cronos Group Inc. (NASDAQ: CRON) shares over potential securities laws violations.

An investigation for investors in Cronos Group Inc. (NASDAQ: CRON) shares over potential securities laws violations.

Cronos Group Inc is under investigation over potential securities laws violations in connection with certain financial statements.

Investors who purchased shares of Cronos Group Inc. (NASDAQ: CRON), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Cronos Group Inc. (NASDAQ: CRON) concerning whether a series of statements by Cronos Group Inc. (NASDAQ: CRON regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Canada based Cronos Group Inc., formerly known as PharmaCan Capital Corp., is a principal investment firm.

On Feb. 24, 2020, Cronos Group Inc announced, without explanation, it would not be (i) timely filing its Q4 and FY 2019 earnings release and (ii) hosting a conference call with investors previously scheduled for Feb. 27, 2020. In response, the price of Cronos shares sharply fell.
On Mar. 2, 2020, Cronos Group Inc revealed the existence of "a continuing review by the Audit Committee of the Company's Board of Directors, with the assistance of outside counsel and forensic accountants, of several bulk resin purchases and sales of products through the wholesale channel and the appropriateness of the recognition of revenue from those transactions." The Company further stated it expects to report for FY 2019: (1) a material inventory write-down; (2) a material decrease in gross profit; and, (3) a material increase in operating loss. This news caused the price of Cronos shares sharply decline during after-hours trading.

Shares of Cronos Group Inc. (NASDAQ: CRON) declined from $9.00 per share on Janaury 21, 2020 to as low as $5.14 per share on March 3, 2020.

Those who purchased shares of Cronos Group Inc. (NASDAQ: CRON) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in Cronos Group Inc. (NASDAQ: CRON) over potential Securities Laws Violations here

News-ID: 1960101 • Views:

More Releases from Shareholders Foundation

Lawsuit DEADLINE Alert: Investors who lost money with Stride, Inc. (NYSE: LRN) shares should contact the Shareholders Foundation
Lawsuit DEADLINE Alert: Investors who lost money with Stride, Inc. (NYSE: LRN) s …
An investor, who purchased shares of Stride, Inc. (NYSE: LRN), filed a lawsuit over alleged violations of Federal Securities Laws by Stride, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Stride, Inc. (NYSE: LRN) have certain options and for certain investors are short and strict deadlines running. Deadline: January 12, 2026. NYSE: LRN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: JHX) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements. Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT)
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced. Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherapeutics (NASDAQ: MLTX)
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements. Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:

All 5 Releases


More Releases for Cronos

Top Crypto to Buy Now: APEMARS, XRP & Cronos - Best Picks with 1000x Potential
Top Crypto to Buy Now Alert: Analysts Forecast This Presale to 1000x With 22,367% ROI - XRP & Cronos Deliver Proven Stability in the Chaos! Crypto stories rarely announce themselves loudly. They appear quietly, move fast, and reward those who notice the shift before the crowd does. Right now, three names keep surfacing in very different conversations: APEMARS, XRP, and Cronos. Each represents a different approach to value in this cycle.
New Crypto Coins 2026: Apeing Leads as Ethereum, Cronos Hold
New Crypto Coins Exploding in 2026: Why Apeing Leads While Ethereum and Cronos Hold Strong Electric momentum is returning to crypto, and timing is becoming everything again. New crypto coins are stepping into the spotlight as traders scan for early conviction plays instead of chasing crowded charts. Apeing https://www.apeing.com is already pulling attention by tapping into raw market instinct rather than waiting for confirmation. When volatility shakes confidence, projects that reward
Best Altcoins to Invest: APEMARS, Ethereum, and Cronos in News
Next 1000x Crypto to Boom in 2026? APEMARS ($APRZ) Leads the Best Altcoins to Invest in Race Alongside Ethereum and Cronos When searching for the best altcoins to invest https://www.apemars.com in 2026, smart money follows three signals: community momentum, structural scarcity, and real utility. Currently, as institutional money pours into established players like Ethereum and strategic ecosystems like Cronos, a new mission is about to launch that could transform early investors
Evaluating the Best Long-Term Cryptocurrencies: BlockDAG, Cronos, WLFI, and AAVE …
Identifying the best long-term crypto investments requires looking beyond short-term price swings and focusing on the underlying mechanics that define a project's durability. In 2025, cryptocurrencies such as BlockDAG, Cronos, WLFI, and AAVE exemplify different approaches to sustainable growth. Each represents a unique model of value creation from BlockDAG's fixed-supply launch and infrastructure focus, to Cronos's exchange-driven ecosystem, WLFI's emerging financial integration, and AAVE's established DeFi foundation. This discussion evaluates different
Cronos Price Prediction, Filecoin News, and The Meme Coin Being Dubbed SHIB 2.0
Meme coins, DeFi platforms, and Layer 1 challengers are shaping the conversation as traders position for the final months of 2025. The market is split between bullish calls around the Cronos price prediction, and optimism surrounding the latest Filecoin news. But in the mix is a presale token https://layerbrett.com already being called "SHIB 2.0,". The question now: where should traders place their bets before Q4 momentum truly kicks in? Layer Brett (LBRETT)
Hemp Derivatives Market Massive Growth opportunity Ahead | Canopy Growth,Aurora, …
"The Global Hemp Derivatives Market Size is projected to reach at a CAGR of 9.1% during 2025-2034." Global Hemp Derivatives market Size, Status, and Forecast for the 2025-2034. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Hemp Derivatives Market including drivers, restraints, historical and current trends, regulatory scenarios, and technological advancements. It provides